Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Identification of the chemokine receptors CCR5 and
CXCR4
as the major coreceptors for
HIV
-1 entry has greatly assisted our understanding of
HIV
-1 pathogenesis, transmission, and tropism. However, most of our current knowledge on coreceptor usage comes from studies using
HIV
-1 strains or env genes derived from the genetic subtype B predominant in North America and western Europe. In this report, the coreceptor usage of 20 primary viral isolates representative of genetic subtypes A, B, C, D, E, and group O was examined. Thirty-nine full-length CCR5 sequences from individuals of diverse geographic origins were also obtained to examine the possible effect of CCR5 polymorphism on
HIV
-1 subtype distribution. Our results indicate that (1) CCR5 and
CXCR4
serve as the two major coreceptors for viruses belonging to
HIV
-1 subtypes A, B, C, D, E, and group O, whereas other chemokine receptors such as CCR2b and CCR3 play only a minor role in facilitating viral entry into stimulated PBMCs; (2) the coreceptor usage is determined by the viral phenotype rather than its genotype because all NSI strains, irrespective of their subtype classification, utilize CCR5, whereas all SI strains are able to use
CXCR4
; and (3) there is no geographic clustering of CCR5 polymorphism in different ethnic populations, suggesting that CCR5 diversity is not the underlying explanation for differences in the spread of different
HIV
-1 subtypes. Therefore, the uneven worldwide distribution of
HIV
-1 subtypes is more likely the result of stochastic dissemination.
...
PMID:HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism. 935 54
Infection with
HIV
-1 requires expression of CD4 and the chemokine receptors
CXCR4
or CCR5 at the target cell surface. Engagement of these receptors by the
HIV
-1 envelope glycoprotein is essential for membrane fusion, but may additionally activate intracellular signaling pathways. In this study, we demonstrate that chemokines and
HIV
-1 envelope glycoproteins from both T-tropic and macrophage-tropic strains rapidly induce tyrosine phosphorylation of the protein tyrosine kinase Pyk2. The response requires
CXCR4
and CCR5 to be accessible on the cell surface. The results presented here provide the first evidence for activation of an intracellular signaling event that can initiate multiple signaling pathways as a consequence of contact between
HIV
-1 and chemokine receptors.
...
PMID:Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. 936 41
Human immunodeficiency virus type 1 (HIV-1) requires both CD4 and a coreceptor to infect cells. Macrophage-tropic (M-tropic)
HIV
-1 strains utilize the chemokine receptor CCR5 in conjunction with CD4 to infect cells, while T-cell-tropic (T-tropic) strains generally utilize
CXCR4
as a coreceptor. Some viruses can use both CCR5 and
CXCR4
for virus entry (i.e., are dual-tropic), while other chemokine receptors can be used by a subset of virus strains. Due to the genetic diversity of
HIV
-1,
HIV
-2, and simian immunodeficiency virus (SIV) and the potential for chemokine receptors other than CCR5 or
CXCR4
to influence viral pathogenesis, we tested a panel of 28
HIV
-1,
HIV
-2, and SIV envelope (Env) proteins for the ability to utilize chemokine receptors, orphan receptors, and herpesvirus-encoded chemokine receptor homologs by membrane fusion and virus infection assays. While all Env proteins used either CCR5 or
CXCR4
or both, several also used CCR3. Use of CCR3 was strongly dependent on its surface expression levels, with a larger number of viral Env proteins being able to utilize this coreceptor at the higher levels of surface expression. ChemR1, an orphan receptor recently shown to bind the CC chemokine I309 (and therefore renamed CCR8), was expressed in monocyte and lymphocyte cell populations and functioned as a coreceptor for diverse
HIV
-1,
HIV
-2, and SIV Env proteins. Use of ChemR1/CCR8 by SIV strains was dependent in part on V3 loop sequences. The orphan receptor V28 supported Env-mediated cell-cell fusion by four T- or dual-tropic
HIV
-1 and
HIV
-2 strains. Three additional orphan receptors failed to function for any of the 28 Env proteins tested. Likewise, five of six seven-transmembrane-domain receptors encoded by herpesviruses did not support Env-mediated membrane fusion. However, the chemokine receptor US28, encoded by cytomegalovirus, did support inefficient infection by two
HIV
-1 strains. These findings indicate that additional chemokine receptors can function as
HIV
and SIV coreceptors and that surface expression levels can strongly influence coreceptor use.
...
PMID:Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. 937 56
Different strains of human immunodeficiency virus type 1 (HIV-1) vary markedly in the ability to infect cells of the monocyte/macrophage (M/M) lineage. M/M are generally resistant to infection with T-cell-tropic (T-tropic) strains of
HIV
-1. Recently, the chemokine receptors CCR5 and
CXCR4
were identified as cofactors for fusion/entry of macrophage- and T-tropic strains of
HIV
-1, respectively. To investigate the mechanisms of resistance of M/M to T-tropic
HIV
-1 infection, we examined a number of subclones of the U937 promonocytic cell line. We found that certain subclones of U937 (plus clones) could, while others (minus clones) could not, support replication of T-tropic strains of
HIV
-1. We demonstrate that (i) both minus and plus clones support
HIV
-1 replication when transfected with an infectious molecular cDNA clone of a T-tropic
HIV
-1; (ii) minus clones do not, but plus clones do, efficiently support fusion with cells expressing
HIV
-1 IIIB Env; (iii) both plus and minus clones (with the exception of one clone) express physiologically functional
CXCR4
protein as well as CD4 on the cell surface; (iv) introduction of
CXCR4
into the
CXCR4
-negative clone does not restore fusogenicity with or susceptibility to T-tropic
HIV
-1; and (v) a ligand (stromal cell-derived factor 1) for or a monoclonal antibody (12G5) to
CXCR4
does not effectively inhibit
HIV
-mediated cell-to-cell fusion of U937 cells. These data indicate that resistance to T-tropic
HIV
-1 infection of U937 minus clones occurs at fusion/ entry events and that expression of functional
CXCR4
and CD4 is not a sole determinant for susceptibility to T-tropic
HIV
-1 infection; furthermore, they suggest that other factors are positively or negatively involved in
HIV
-mediated cell-to-cell fusion in U937 promonocytic cells.
...
PMID:Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. 937 31
The chemokine receptor CXCR4 (also designated fusin and LESTR) is a cofactor for fusion and entry of T cell-tropic strains of
HIV
-1.
CXCR4
is expressed in various cell types; however, the mechanisms involved in the regulation of its expression remain unknown. To delineate these mechanisms, approximately 1.2 kb of DNA from the immediate 5' upstream region of
CXCR4
gene was cloned, sequenced, and characterized. Transient expression assays using
CXCR4
promoter/luciferase gene reporter constructs revealed that stimulation with PMA plus ionomycin up-regulates the
CXCR4
promoter activity in the A3.01 CD4+ T cell line and PBL and that a DNA fragment from -93 to +59 relative to the transcription start site contributes markedly to the basal and induced activity. This fragment contains a consensus TATA box, two potential GC boxes, and a potential nuclear respiratory factor (NRF)-1 binding site, which were confirmed by gel mobility shift assays and footprinting analysis. Mutagenesis studies revealed that a NRF-1 site is especially important for the basal and induced activity of the
CXCR4
promoter. Transient expression assays further revealed that stimulation of PBL with either IL-2 or Abs to CD3 and CD28 enhances the
CXCR4
promoter activity. Inducibility of the
CXCR4
promoter activity by T cell stimulation suggests that overexpression of
CXCR4
may be one of the mechanisms whereby immune activation and/or perturbation of the cytokine network up-regulate
HIV
expression and replication and thus contribute to the progression of
HIV disease
.
...
PMID:Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. 937 28
The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was determined by NMR spectroscopy. SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution. Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation. Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists. Residues 12-17 of the loop region, which we term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure. The RFFESH formed a receptor binding site, which we propose to be an important initial docking site of SDF-1 with its receptor. The ability of the SDF-1 analogs to block
HIV
-1 entry via
CXCR4
, which is a
HIV
-1 coreceptor for the virus in addition to being the receptor for SDF-1, correlated with their affinity for
CXCR4
. Activation of the receptor is not required for
HIV
-1 inhibition.
...
PMID:Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. 938 79
Transmission of
HIV
-1 is predominantly restricted to macrophage (Mphi)-tropic strains. Langerhans cells (LCs) in mucosal epithelium, as well as macrophages located in the submucosal tissues, may be initial targets for
HIV
-1. This study was designed to determine whether restricted transmission of
HIV
-1 correlates with expression and function of
HIV
-1 co-receptors on LCs and macrophages. Using polyclonal rabbit IgGs specific for the
HIV
co-receptors cytokines
CXCR4
and CCR5, we found that freshly isolated epidermal LCs (resembling resident mucosal LCs) expressed CCR5, but not CXCR, on their surfaces. In concordance with surface expression, fresh LCs fused with Mphi-tropic but not with T-tropic
HIV
-1 envelopes. However, fresh LCs did contain intracellular
CXCR4
protein that was transported to the surface during in vitro culture. Macrophages expressed high levels of both co-receptors on their surfaces, but only CCR5 was functional in a fusion assay. These data provide several possible explanations for the selective transmission of Mphi-tropic
HIV
variants and for the resistance to infection conferred by the CCR5 deletion.
...
PMID:Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. 939 95
Brain capillary endothelial cells (BCECs) are targets of CD4-independent infection by
HIV
-1 and simian immunodeficiency virus (SIV) strains in vitro and in vivo. Infection of BCECs may provide a portal of entry for the virus into the central nervous system and could disrupt blood-brain barrier function, contributing to the development of AIDS dementia. We found that rhesus macaque BCECs express chemokine receptors involved in
HIV
and SIV entry including CCR5, CCR3,
CXCR4
, and STRL33, but not CCR2b, GPR1, or GPR15. Infection of BCECs by the neurovirulent strain SIV/17E-Fr was completely inhibited by aminooxypentane regulation upon activation, normal T cell expression and secretion in the presence or absence of ligands, but not by eotaxin or antibodies to CD4. We found that the envelope (env) proteins from SIV/17E-Fr and several additional SIV strains mediated cell-cell fusion and virus infection with CD4-negative, CCR5-positive cells. In contrast, fusion with cells expressing the coreceptors STRL33, GPR1, and GPR15 was CD4-dependent. These results show that CCR5 can serve as a primary receptor for SIV in BCECs and suggest a possible CD4-independent mechanism for blood-brain barrier disruption and viral entry into the central nervous system.
...
PMID:CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. 940 83
We have studied the breadth and potency of the inhibitory actions of the CC chemokines macrophage inhibitory protein 1alpha (MIP-1alpha), MIP-1beta, and RANTES against macrophage-tropic (M-tropic) primary isolates of human immunodeficiency virus type 1 (HIV-1) and of the CXC chemokine stromal cell-derived factor 1alpha against T-cell-tropic (T-tropic) isolates, using mitogen-stimulated primary CD4+ T cells as targets. There was considerable interisolate variation in the sensitivity of
HIV
-1 to chemokine inhibition, which was especially pronounced for the CC chemokines and M-tropic strains. However, this variation was not obviously dependent on the genetic subtype (A through F) of the virus isolates. Peripheral blood mononuclear cell donor-dependent variation in chemokine inhibition potency was also observed. Among the CC chemokines, the rank order for potency (from most to least potent) was RANTES, MIP-1beta, MIP-1alpha. Some M-tropic isolates, unexpectedly, were much more sensitive to RANTES than to MIP-1beta, whereas other isolates showed sensitivities comparable to those of these two chemokines. Down-regulation of the CCR5 and
CXCR4
receptors occurred in cells treated with the cognate chemokines and probably contributes to anti-
HIV
-1 activity. Thus, for CCR5, the rank order for down-regulation was also RANTES, MIP-1beta, MIP-1alpha.
...
PMID:Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. 942 Feb 38
Human immunodeficiency virus type 1 (HIV-1) entry into target cells is a multistep process initiated by envelope protein gp120 binding to cell surface CD4. The conformational changes induced by this interaction likely favor a second-step interaction between gp120 and a coreceptor such as
CXCR4
or CCR5. Here, we report a spontaneous and stable CD4-independent entry phenotype for the
HIV
-1 NDK isolate. This mutant strain, which emerged from a population of chronically infected CD4-positive CEM cells, can replicate in CD4-negative human cell lines. The presence of
CXCR4
alone renders cells susceptible to infection by the mutant NDK, and infection can be blocked by the
CXCR4
natural ligand SDF-1. Furthermore, we have correlated the CD4-independent phenotype with seven mutations in the C2 and C3 regions and the V3 loop. We propose that the mutant gp120 spontaneously acquires a conformation allowing it to interact directly with
CXCR4
. This virus provides us with a powerful tool to study directly gp120-
CXCR4
interactions.
...
PMID:Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. 942 Feb 53
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>